Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Lung Adenocarcinoma · Lung Large Cell Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Stage III Lung Cancer AJCC v8

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Keck Medicine of USC Buena Park, Buena Park, California, United States

    Contact: Study coordinator (Site Public Contact) · 714-522-0908
    Contact: Principal Investigator (Jason C. Ye)
  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Jyoti Malhotra)
  • City of Hope at Irvine Lennar, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-467-3411
    Contact: Principal Investigator (Jyoti Malhotra)
  • City of Hope Antelope Valley, Lancaster, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Jyoti Malhotra)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Jason C. Ye)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Jason C. Ye)
  • USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Jason C. Ye)
  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

  • City of Hope South Pasadena, South Pasadena, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Jyoti Malhotra)
  • City of Hope Upland, Upland, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Jyoti Malhotra)
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Richa Dawar)
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Richa Dawar)
  • UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · cancer-center@ufl.edu · 352-273-8010
    Contact: Principal Investigator (Tithi Biswas)
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Richa Dawar)
  • UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Richa Dawar)
  • UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Richa Dawar)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Everett E. Vokes)
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Everett E. Vokes)
  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Everett E. Vokes)
  • UChicago Medicine Northwest Indiana, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
    Contact: Principal Investigator (Everett E. Vokes)
  • Jersey City Medical Center, Jersey City, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Salma K. Jabbour)
  • Saint Barnabas Medical Center, Livingston, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · joanne.loeb@rwjbh.org · 973-322-2934
    Contact: Principal Investigator (Salma K. Jabbour)
  • Monmouth Medical Center, Long Branch, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · mary.danish@rwjbh.org · 732-923-6564
    Contact: Principal Investigator (Salma K. Jabbour)
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Salma K. Jabbour)
  • Newark Beth Israel Medical Center, Newark, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · Christine.Kosmides@rwjbh.org · 973-926-7230
    Contact: Principal Investigator (Salma K. Jabbour)
  • Robert Wood Johnson University Hospital Somerset, Somerville, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · Siby.Varughese@rwjbh.org · 908-685-2481
    Contact: Principal Investigator (Salma K. Jabbour)
  • Community Medical Center, Toms River, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · Lennette.Gonzales@rwjbh.org · 732-557-8294
    Contact: Principal Investigator (Salma K. Jabbour)
  • Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States

  • Montefiore Medical Center - Moses Campus, The Bronx, New York, United States

  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-713-6771
    Contact: Principal Investigator (Thomas W. Lycan)
  • Case Western Reserve University, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Afshin Dowlati)
  • MetroHealth Medical Center, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · ababal@metrohealth.org · 216-778-7559
    Contact: Principal Investigator (Peter Xie)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Liza C. Villaruz)
  • University of Texas Medical Branch, Galveston, Texas, United States

מובילי המחקר
  • Afshin Dowlati

    Principal Investigator

    Case Western Reserve University